Effects of 1:6-Dimethane-Sulphonyl-D-Mannitol in Animal Experiments
Author Information
Author(s): B. Kellner, L. Németh
Primary Institution: Research Institute of Oncopathology, Budapest, Hungary
Hypothesis
The compound 1:6-dimethane-sulphonyl-D-mannitol will exhibit lower toxicity and effective tumor-inhibiting properties compared to Myleran.
Conclusion
1:6-Dimethane-sulphonyl-D-mannitol is much less toxic than Myleran and shows significant tumor-inhibiting effects.
Supporting Evidence
- The compound was shown to inhibit the growth of various transplantable tumors.
- 1:6-Dimethane-sulphonyl-D-mannitol was found to be less toxic than Myleran.
- Significant morphological changes were observed in tumor cells after treatment.
- The compound demonstrated a protective action against metastasis in treated animals.
Takeaway
A new medicine made from sugar can help fight cancer without making animals very sick.
Methodology
The study involved administering varying doses of the compound to different animal models and observing the effects on tumor growth and blood parameters.
Limitations
Further studies are needed to confirm the long-term effects and potential carcinogenicity of the compound.
Participant Demographics
Animal models including rats and mice were used in the experiments.
Want to read the original?
Access the complete publication on the publisher's website